Principles of pharmacology / (Record no. 1478)

MARC details
000 -LEADER
fixed length control field 05360cam a22004817i 4500
001 - CONTROL NUMBER
control field data
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260322212102.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field data
035 ## - SYSTEM CONTROL NUMBER
System control number 22339083
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2020300616
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 019672491
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781642652994
Qualifying information (hardcover)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1642652997
Qualifying information (hardcover)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1114599760
040 ## - CATALOGING SOURCE
Original cataloging agency YFM
Language of cataloging eng
Transcribing agency YFM
Description conventions rda
Modifying agency DLC
-- OCLCO
-- MLY
-- R2A
-- IBI
-- YDXIT
-- CES
-- TKL
-- OCLCO
-- OCLCA
-- RC9
-- UKMGB
-- OCLCO
-- YDX
-- BDX
-- DON
-- JYJ
-- OCLCO
-- DLC
042 ## - AUTHENTICATION CODE
Authentication code lccopycat
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM300
Item number .P743 2019
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 704
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615
Edition information 23
245 00 - TITLE STATEMENT
Title Principles of pharmacology /
Statement of responsibility, etc. editor, Richard Renneboog, MSc.
246 30 - VARYING FORM OF TITLE
Title proper/short title Pharmacology
250 ## - EDITION STATEMENT
Edition statement [First edition].
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture [Amenia, New York] :
Name of producer, publisher, distributor, manufacturer Grey House Publishing,
Place of production, publication, distribution, manufacture [Amenia, New York] :
Name of producer, publisher, distributor, manufacturer Grey House Publishing,
Date of production, publication, distribution, manufacture, or copyright notice [2019]
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2019
300 ## - PHYSICAL DESCRIPTION
Extent xiii, 420 pages :
Other physical details illustrations ;
Dimensions 26 cm
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Media type code n
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Carrier type code nc
Source rdacarrier
490 0# - SERIES STATEMENT
Series statement Principles of
490 1# - SERIES STATEMENT
Series statement [Principles of science]
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Acetaminophen -- Alkylating agents in chemotherapy -- Allergies -- Aminoglycoside antibiotics -- Amiodarone -- Amoxicillin -- Androgen drugs -- Angiogenesis inhibitors -- Antacids -- Anthrax vaccine -- Antiandrogens (cancer treatment) -- Antianxiety drugs -- Antibiotics: Experimental -- Antibiotics: Overview -- Antibiotics: Types -- Antibodies -- Anticholinergics -- Antidepressant medications -- Antidiarrheal agents -- Antiestrogens -- Antifungal drugs -- Antimetabolites in chemotherapy -- Antinausea medications -- Antineoplastics in chemotherapy -- Antiparasitic drugs -- Antipsychotic medications -- Antiviral drugs -- Bacillus Calmette-Guérin (BCG) -- Benzodiazepines -- Beta-blockers -- Biopharmaceuticals -- Bisphosphonates -- Branched-chain amino acids (BCAAs) -- Bromocriptine -- Brompton cocktail -- Calcium channel blockers -- Cancer vaccines -- Carbamazepine -- Cephalosporin antibiotics -- Chemical germicides -- Cisplatin -- Clonidine -- Colchicine -- Corticosteroids -- Cyclooxygenase-2 (COX-2) inhibitors -- Cyclosporine -- Cytokines -- Delta-9-tetrahydrocannabinol (THC) -- Designer drugs -- Diindolylmethane -- Dopamine and addiction -- Doxorubicin -- Endocrinology -- Essential oil monoterpenes -- Estriol -- Estrogen -- Estrogen receptor downregulator (ERD) -- Ethambutol -- Fentanyl -- Gamma oryzanol -- Gene therapy -- General antibiotics -- Glutamine -- Heparin -- Hepatitis vaccines -- Histamine 2 antagonists -- HIV vaccine -- Hormones -- Huperzine A -- Hydroxycitric acid -- Hydroxymethylbutyrate -- Hyperbaric oxygen therapy -- Imidazole antifungals -- Influenza -- Influenza vaccine -- Insulin -- Integrase inhibitors -- Interferon -- Interleukins -- Iodine -- Ipriflavone -- Isoniazid -- Ketolide antibiotics -- Laxatives -- Lipoic acid -- Lipopeptide antibiotics -- Living with allergies -- Loop diuretics -- Macrolide antibiotics -- Marijuana -- Matrix metalloproteinase inhibitors -- Maturation inhibitors -- Melatonin -- Mesoglycan -- Metabolism -- Methotrexate -- Monoamine oxidase inhibitors (MAOI) -- Monoclonal antibodies -- Narcotics -- Nicotine -- Nicotine replacement products -- Nitrofurantoin -- Nitroglycerin -- Nonsteroidal anti-inflammatory drugs (NSAIDs) -- Opioids -- Oral contraceptives -- Over-the-counter (OTC) drugs -- Over-the-counter (OTC) drugs: cautions and precautions -- Oxazolidinone antibiotics -- Pain management medications -- Penicillamine -- Penicillin antibiotics -- Pentoxifylline -- Pharmacognosy and pharmacology -- Phenobarbital -- Phenothiazines -- Phenytoin -- Plant alkaloids and terpenoids in chemotherapy -- Primidone -- Protease inhibitors -- Proteasome inhibitors -- Psychopharmacology -- Quinolone antibiotics -- Radiopharmaceuticals -- Reverse transcriptase inhibitors -- Schistosomiasis vaccine -- Serotonin -- Steroids -- Tetracycline antibiotics -- Thalidomide -- Thiazide diuretics -- Thiazole antifungals -- Thyroid hormone -- Tocotrienols -- Topoisomerase inhibitors -- Tramadol -- Tricyclic antidepressants -- Trimethoprim/sulfamethoxazole -- Trimethylglycine -- Trypanosomiasis vaccine -- Tumor necrosis factor (TNF) -- Typhus vaccine -- Tyrosine kinase inhibitors -- Tyrosine -- Vaccines -- Valproic acid -- Vitamins and minerals -- Warfarin -- Weight loss medications -- Timeline of major events in pharmacology -- The Nobel Prize in physiology or medicine 1901-2018 -- Glossary.
520 ## - SUMMARY, ETC.
Summary, etc. This book addresses a variety of topics in the field of pharmacology. Entries related to basic principles and concepts include fields of study related to the topic; an abstract that provides a brief, concrete summary of the topic; and key concepts important to a proper understanding of the topic.--
Assigning source Source other than the Library of Congress.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Edition statement supplied by publisher.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst01060259
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Renneboog, Richard,
Relator term editor.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Principles of science.
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c copycat
d 2
e ncip
f 20
g y-gencatlg
925 0# -
-- acquire
-- 1 shelf copy
-- Sel/rjc, 2022-04-15
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Total checkouts Full call number Barcode Date last seen Price effective from Koha item type
        Riverside Riverside General stacks 22/03/2026   615 LOC-RPL-00025 22/03/2026 22/03/2026 Books